Christian Grommes, MD, shares results from a phase 2 study evaluating ibrutinib plus rituximab, methotrexate, vincristine, and procarbazine in PSNCL.
Christian Grommes, MD
Advertisement
Christian Grommes, MD, is a neuro-oncologist and associate attending physician at Memorial Sloan Kettering Cancer Center.
Articles by Christian Grommes, MD
Advertisement
Latest Updated Articles
Dr Grommes on the Addition of Ibrutinib to R-MPV Induction in Newly Diagnosed PCNSLPublished: November 24th 2025 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
FDA Approval Tees Up T-DXd Plus Pertuzumab as a New SOC in HER2+ Breast Cancer
2
FDA Advises on Next Steps for Nogapendekin Alfa Inbakicept Plus BCG sBLA in BCG-Unresponsive Papillary NMIBC
3
Iberdomide Plus Daratumumab/Dexamethasone Displays High Response Rates in NDMM
4
NALIRIFOX and FOLFIRINOX Facilitate Personalized Treatment in Metastatic Pancreatic Cancer
5